Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.
Journal: The Journal of clinical investigation
Published: September 23, 2016
Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 27, 2014
Immune-checkpoint blockade and active immunotherapy for glioma.
Journal: Cancers
Published: September 16, 2013
Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 09, 2012
Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.
Journal: Neuro-oncology
Published: March 13, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026